Rath Cellular Solution (Dr. Matthias Rath)

Rath Cellular Solution (Dr. Matthias Rath)

This treatment stops the spreading of cancer. This same treatment is also used to prevent heart disease.


New Research Says Some Nutrients Can Inhibit Pancreatic Cancer Growth

Innovative research conducted by scientists under the direction of Aleksandra Niedzwiecki, Ph.D., at the Dr. Rath Research Institute indicates that the spread of pancreatic cancer can be inhibited with a specific nutrient combination. The research findings, published in the latest issue of the International Journal of Gastrointestinal Cancer (2005,Volume 35:2; 97-102), further validate Dr. Matthias Rath's novel approach to controlling cancer metastasis with essential nutrients.

There is no cure for pancreatic cancer, which has the poorest prognosis among cancer malignancies. Conventional approaches, including surgery, chemotherapy and radiation, have been unsuccessful reducing the high mortality rate of this disease. Dr. Rath's research team incubated the human pancreatic cell line MIA PaCa-2 with a nutrient mixture composed of vitamin C, lysine, other amino acids, and green tea to observe its effects in inhibiting the proliferation and invasion of this deadly form of cancer.

This research direction was inspired by Dr. Rath's work. In 1992, he postulated that vitamin C and lysine could act as natural inhibitors of the degradation of connective tissue, a common pathomechanism in all types of malignancies. The study results corroborated earlier research with different types of cancer and showed that the nutrient mixture exerted a significant anti-proliferative effect and completely inhibited the invasion of pancreatic cancer cells. These nutrients also reduced the secretion of matrix metalloproteinases (MMPs), the enzymes that cancer cells use to degrade the surrounding connective tissue and spread in the body.

"Our research proves that specific nutrients can control pancreatic and other forms of cancer because they target the four characteristics of the disease — proliferation, invasion, new blood vessel formation, and cell survival," Dr. Niedzwiecki said. "These new data call for a critical revision of current approaches to cancer and a focus on the development of natural, safe, and effective means of controlling this devastating illness."

Share this with your friends

PROTEIN CODE

The protein code, the second major biological language beside the genetic code, has been discovered. This discovery can lead to recognition of the language human diseases use to communicate and grow, according to a scientific article by Matthias Rath, M.D., in a recent issue of The Journal of Applied Nutrition. Dr. Rath is founder and President of Health Now, Inc., a California-based research and development firm.

The discovery of the protein code has immediate therapeutic implications. Peptide Interception Therapy (PIT) can lead to new and more effective therapies for many of our major diseases, including cancer, heart disease, AIDS, diabetes, hepatitis, and many other infectious diseases. The potential clinical application of PIT affects all areas of medicine.
Dr. Rath says that the discovery can lead to the development of Direct Peptide Interception Therapy and Indirect Peptide Interception Therapy through the use of synthetic analogs. In Direct Interception Therapy the analogs would be used to inhibit undesired protein communication. In the Indirect Interception Therapy they would be used as vaccines.
PIT is specific therapeutic interception of undesired biological actions and interactions by the therapeutic use of synthetic analogs to hydrophilic signal oligopeptides.

"In Competitive Inhibition use of Direct PIT, therapeutic peptides can be used as competitive inhibitors of a specific pathological communication pathway. Direct competitive blocking of pathological communications during virtually any disease must lead to the control of this disease," the article states.

Indirect PIT used as a vaccine could stimulate the production of specific antibodies which block the signal transfer of a specific pathological communication.

"The great advantage of oligopeptide vaccines, compared to conventional vaccines, is that the entire protein is not used as vaccine, but only short synthetic analogs to one or more of the hydrophilic signal oligopeptides of the selected protein. The antibodies produced against these therapeutic oligopeptides can block the undesired interaction of the entire pathogenicity mediating protein," according to the article.

"Like the human language, the protein code consists of letters, sentences, and words," Dr. Rath says. "Of particular importance are the protein code verbs which are generally represented by one or more hydrophilic signal oligopeptides within the protein sequence. The determining principles of the protein code are: universality, compatibility, legibility, accessibility, variability, specificity, discrimination, differentiation, interception, and regulation. Most importantly, the protein code provides the rationale for deciphering the communication code of human disease."

Clinical application of PIT could come much more quickly than the gene therapy which resulted from discovery of the genetic code, the article states. The time and expense for the development of therapeutic peptides would be a fraction of conventional therapeutic research and development, according to the article.

The Journal of Applied Nutrition is one of the oldest peer-reviewed, scientific journals devoted to nutrition. It is now in its 46th consecutive year of publication. The Journal, edited by James Heffley, Ph.D., of Austin, Texas, is the official publication of the International Academy of Nutrition and Preventive Medicine.

Correspondence:

The Journal of Applied Nutrition
P.O. Box 18433
Asheville, NC 28814
704-258-3243
Article copyright Townsend Letter for Doctors & Patients.